...
首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >CD4+CD25+Foxp3+ regulatory T cell formation requires more specific recognition of a self-peptide than thymocyte deletion
【24h】

CD4+CD25+Foxp3+ regulatory T cell formation requires more specific recognition of a self-peptide than thymocyte deletion

机译:与胸腺细胞缺失相比,CD4 + CD25 + Foxp3 +调节性T细胞的形成需要对自身肽的更特异性识别

获取原文
获取原文并翻译 | 示例
           

摘要

CD4+CD25+Foxp3+ regulatory T (Treg) cells are generated during thymocyte development and play a crucial role in preventing the immune system from attacking the body's cells and tissues. However, how the formation of these cells is directed by T-cell receptor (TCR) recognition of self-peptide:major histocompatibility complex (MHC) ligands remains poorly understood. We show that an agonist self-peptide with which a TCR is strongly reactive can induce a combination of thymocyte deletion and CD4+CD25+Foxp3+ Treg cell formation in vivo. A weakly cross-reactive partial agonist self-peptide could similarly induce thymocyte deletion, but failed to induce Treg cell formation. These studies indicate that CD4+CD25+Foxp3+ Treg cell formation can require highly stringent recognition of an agonist self-peptide by developing thymocytes. They also refine the "avidity" model of thymocyte selection by demonstrating that the quality of the signal mediated by agonist self-peptides, rather than the overall intensity of TCR signaling, can be a critical factor in directing autoreactive thymocytes to undergo CD4+CD25+Foxp3+ Treg cell formation and/or deletion during their development.
机译:CD4 + CD25 + Foxp3 +调节性T(Treg)细胞在胸腺细胞发育过程中产生,在防止免疫系统攻击人体的细胞和组织中起着至关重要的作用。但是,如何通过T细胞受体(TCR)识别自身肽:主要组织相容性复合物(MHC)配体来指导这些细胞的形成仍知之甚少。我们显示,与TCR具有强反应性的激动剂自身肽可以在体内诱导胸腺细胞缺失和CD4 + CD25 + Foxp3 + Treg细胞形成的组合。弱交叉反应的部分激动剂自肽可以类似地诱导胸腺细胞缺失,但不能诱导Treg细胞形成。这些研究表明,CD4 + CD25 + Foxp3 + Treg细胞的形成可能需要通过发育胸腺细胞来高度严格地识别激动剂自身肽。他们还证明了激动剂自身肽介导的信号质量而非TCR信号传导的整体强度可能是指导自身反应性胸腺细胞进行CD4 + CD25 +的关键因素,从而完善了胸腺细胞选择的“抗体”模型。 Foxp3 + Treg细胞在发育过程中形成和/或缺失。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号